S22-040 Targeting Histone Modifier KDMA2 to Enhance Immunotherapy for Cancer Scientists in the Sunwoo Lab at Stanford have discovered that inhibition of the histone lysine demethylase KDMA2 can enhance the efficacy of immune checkpoint blockade therapies, like anti-PD-1. John Sunwoo June Ho Shin Chen Chen